Vitalhub (TSE:VHI) PT Raised to C$10.50

Vitalhub (TSE:VHI) had its price target hoisted by stock analysts at Cormark from C$9.50 to C$10.50 in a report issued on Wednesday, BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Cormark’s price objective suggests a potential upside of 19.59% from the company’s current price. Cormark also issued estimates for Vitalhub’s FY2025 earnings at $0.22 EPS.

Vitalhub Stock Up 2.1 %

VHI stock opened at C$8.78 on Wednesday. The stock has a 50-day simple moving average of C$8.31 and a two-hundred day simple moving average of C$7.31. Vitalhub has a twelve month low of C$2.75 and a twelve month high of C$9.09. The firm has a market capitalization of C$446.46 million, a PE ratio of 79.82, a PEG ratio of 1.18 and a beta of 1.26.

Vitalhub (TSE:VHI) last posted its earnings results on Thursday, August 8th. The company reported C($0.01) EPS for the quarter, missing the consensus estimate of C$0.06 by C($0.07). The business had revenue of C$16.24 million for the quarter, compared to analysts’ expectations of C$15.39 million. Vitalhub had a return on equity of 4.73% and a net margin of 8.14%. On average, equities research analysts anticipate that Vitalhub will post 0.2301144 EPS for the current fiscal year.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.